Position in NKTR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,943,000
+$19,105,322 QoQ
Shares Held
300,000
+127.7% QoQ
Ownership
0.879%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#25
of 239 holders
Holding Since
Dec 2021
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Derivatives in NKTR
reported options exposure · as of Mar 31, 2022CallValue
$5,390,000
CallShares
66,667
PutValue
$2,695,000
PutShares
33,333
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Deep Track Capital, LP holds $5,341,997,223 across 58 Biotechnology names. NKTR ranks #47 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMVT |
Immunovant, Inc.
|
9,341,151 | $359,914,548 | |
| 2 | GPCR |
Structure Therapeutics Inc.
|
4,740,072 | $254,399,664 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
4,300,000 | $249,959,000 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
825,000 | $248,349,750 | |
| 5 | MANE |
Veradermics, Inc
|
2,000,000 | $245,880,000 | |
| 6 | TARS |
Tarsus Pharmaceuticals, Inc.
|
3,666,768 | $230,786,377 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
19,686,282 | $193,319,289 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
3,307,481 | $189,254,062 |
All Filings in NKTR
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,943,000 | 300,000 | Shares | Sole | 2026-08-14 | |
| 2024-12-31 | $1,837,678 | 1,975,998 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $20,699,451 | 15,922,655 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $22,165,617 | 17,875,498 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $17,112,000 | 18,400,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $10,304,000 | 18,400,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,040,000 | 18,400,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,424,609 | 17,973,464 | Shares | Sole | 2023-09-06 | |
| 2023-03-31 | $1,220,273 | 1,743,248 | Shares | Sole | 2023-05-15 | |
| 2022-03-31 | $5,390,000 | 1,000,000 | Call | Sole | 2022-05-16 | |
| 2022-03-31 | $2,695,000 | 500,000 | Put | Sole | 2022-05-16 | |
| 2021-12-31 | $6,755,000 | 500,000 | Put | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||